ASB15-AS1

Across TCGA pan-cancer cohorts, ASB15-AS1 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated ASB15-AS1 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher ASB15-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ASB15-AS1 expression acts as an unfavorable survival marker, although some lineages such as MESO show a favorable association.

BLCA, KICH, and KIRC are the cancer types where ASB15-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	III,IV	0.328	0.567	<.001	111	view →
KICH	OS	Tertile	All	0.520	0.917	<.001	99	view →
KIRC	DFS	Quartile	All	0.686	0.827	.001	70	view →
COAD	OS	Tertile	IV	0.045	0.659	<.001	36	view →
READ	DFS	Tertile	All	0.258	0.711	<.001	36	view →
DLBC	OS	Tertile	III,IV	0.154	0.735	.010	28	view →
BRCA	DFS	Tertile	All	0.357	0.550	.006	18	view →
OV	DFS	Tertile	IV	0.295	0.495	.033	18	view →
LUAD	DFS	Tertile	IV	0.223	0.710	.043	18	view →
PAAD	DFS	Tertile	II,III,IV	0.135	0.482	.002	18	view →
MESO	OS	Tertile	All	0.714	0.500	.030	12	view →
PRAD	OS	Tertile	All	0.979	0.997	.012	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

ASB15-AS1–BLCA (DFS)

Open the BLCA breakdown →